High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.
<h4>Background</h4>There is good evidence in the literature that the cannabinoid system is disturbed in colorectal cancer. In the present study, we have investigated whether CB(1) receptor immunoreactive intensity (CB(1)IR intensity) is associated with disease severity and outcome.<h4...
Guardado en:
Autores principales: | Sofia B Gustafsson, Richard Palmqvist, Maria L Henriksson, Anna M Dahlin, Sofia Edin, Stig O P Jacobsson, Åke Öberg, Christopher J Fowler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f94b9e5d28d4124b610b54a3ffed347 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
por: Sofia Edin, et al.
Publicado: (2012) -
Cholesterol as a modulator of cannabinoid receptor CB2 signaling
por: Alexei Yeliseev, et al.
Publicado: (2021) -
Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration.
por: Martin Häring, et al.
Publicado: (2011) -
Comparison of Clinical and Histopathological Parameters amongst Microsatellite Unstable and Microsatellite Stable Cases of Colorectal Carcinomas in an Indian Setting
por: Divya Shelly, et al.
Publicado: (2021) -
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
por: Marjolein Soethoudt, et al.
Publicado: (2017)